Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate

Archives of Dermatological Research

Volumn 302, Issue 3, 2010, Pages 183-189

  Trompezinski, Sandra ^a,b   Bonneville, Marlène ^c   Pernet, Ingrid ^b   Denis, Alain ^c   Schmitt, Daniel ^a   Viac, Jacqueline ^a  

^a UNIVERSITÉ DE LYON   (France)

^b DIPTA   (France)

^c Bioderma Laboratoire Dermatologique   (France)

Author keywords

CXCL8 IL 8; EGCG; Ginkgo biloba; Inflammation; Normal human keratinocyte; VEGF

Indexed keywords

EPIGALLOCATECHIN GALLATE; GINKGO BILOBA EXTRACT; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL ACTIVATION; CELL LEVEL; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SKIN DISEASE;

ANTI-INFLAMMATORY AGENTS; CATECHIN; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GINKGO BILOBA; HUMANS; INTERLEUKIN-8; KERATINOCYTES; MALE; PLANT EXTRACTS; PLANT LEAVES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77949269054     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-0979-x     Document Type: Article

References (41)

1. M Baggiolini B Dewald B Moser 1994 Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines Adv Immunol 55 97 179 10.1016/S0065-2776(08) 60509-X 1:CAS:528:DyaK2cXktlamtr8%3D 8304236
2. C Ballaun W Weninger A Uthman, et al. 1995 Human keratinocytes express the three major splice forms of vascular endothelial growth factor J Invest Dermatol 104 7 10 10.1111/1523-1747.ep12613450 1:CAS:528:DyaK2MXjvFSks70%3D 7798644
3. D Castelli L Colin E Camel, et al. 1998 Pretreatment of skin with a Ginkgo biloba extract/sodium carboxymethyl-beta-1, 3-glucan formulation appears to inhibit the elicitation of allergic contact dermatitis in man Contact Dermat 38 123 126 10.1111/j.1600-0536.1998.tb05676.x 1:CAS:528:DyaK1cXitVGlsLo%3D (Pubitemid 28118878)
4. F Cheung Siow Yl Chen Wz, et al. 1999 Inhibitory effect of Ginkgo biloba extract on the expression of inducible nitric oxide synthase in endothelial cells Biochem Pharmacol 58 1665 1673 10.1016/S0006-2952(99)00255-5 1:CAS:528:DyaK1MXmvVKisb4%3D 10535759 (Pubitemid 29468772)
5. FV Defeudis V Papadopoulos K Drieu 2003 Ginkgo biloba extracts and cancer: a research area in its infancy Fundam Clin Pharmacol 17 405 417 10.1046/j.1472-8206.2003.00156.x 1:CAS:528:DC%2BD3sXlvFCnt7w%3D 12914542 (Pubitemid 36920641)
6. N Ferrara T Davis-Smyth 1997 The biology of vascular endothelial growth factor Endocr Rev 18 4 25 10.1210/er.18.1.4 1:CAS:528:DyaK2sXhsFCiu7s%3D 9034784 (Pubitemid 27076453)
7. S Frank G Hubner G Breier, et al. 1995 Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing J Biol Chem 270 12607 12613 10.1074/jbc.270.46.27429 1:CAS:528:DyaK2MXlvFOiurw%3D 7759509
8. H Fujiki M Suganuma S Okabe, et al. 1999 Mechanistic findings of green tea as cancer preventive for humans Proc Soc Exp Biol Med 220 225 228 10.1046/j.1525-1373.1999.d01-38.x 1:CAS:528:DyaK1MXjsl2qtb0%3D 10202393
9. AH Gomaa M Yaar MM Eyada, et al. 2007 Lymphangiogenesis and angiogenesis in non-phymatous rosacea J Cutan Pathol 34 748 753 10.1111/j.1600-0560.2006. 00695.x 17880579 (Pubitemid 47459684)
10. H Huh E Staba 1992 The botany and chemistry of Ginkgo biloba L J Herbs Spices Med Plants 1 92 124 10.1300/J044v01n01-10
11. CP Juarez JC Muino H Guglielmone, et al. 2000 Experimental retinopathy of prematurity: angiostatic inhibition by nimodipine, ginkgo-biloba, and dipyridamole, and response to different growth factors Eur J Ophthalmol 10 51 59 1:STN:280:DC%2BD3c3gs1SksQ%3D%3D 10744206
12. S Kanowski WM Herrmann K Stephan, et al. 1996 Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia Pharmacopsychiatry 29 47 56 10.1055/s-2007-979544 1:STN:280: DyaK283pvVSrsg%3D%3D 8741021
13. SK Katiyar N Ahmad H Mukhtar 2000 Green tea and skin Arch Dermatol 136 989 994 10.1001/archderm.136.8.989 1:STN:280:DC%2BD3cvhs1yqsg%3D%3D 10926734
14. BH Kim YS Lee KS Kang 2003 The mechanism of retinol-induced irritation and its application to anti-irritant development Toxicol Lett 146 65 73 10.1016/j.toxlet.2003.09.001 1:CAS:528:DC%2BD3sXovVWrsLo%3D 14615068 (Pubitemid 37410230)
15. SJ Kim 2001 Effect of biflavones of Ginkgo biloba against UVB-induced cytotoxicity in vitro J Dermatol 28 193 199 1:CAS:528:DC%2BD3MXlvVCrs7w%3D 11449670
16. WJ Kwak CK Han KH Son, et al. 2002 Effects of Ginkgetin from Ginkgo biloba Leaves on cyclooxygenases and in vivo skin inflammation Planta Med 68 316 321 10.1055/s-2002-26742 1:CAS:528:DC%2BD38XjvFShsrw%3D 11988854 (Pubitemid 34494041)
17. CG Larsen AO Anderson JJ Oppenheim, et al. 1989 Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor Immunology 68 31 36 1:CAS:528: DyaL1MXmtFejurk%3D 2478449
18. H Lim KH Son HW Chang, et al. 2006 Effects of anti-inflammatory biflavonoid, ginkgetin, on chronic skin inflammation Biol Pharm Bull 29 1046 1049 10.1248/bpb.29.1046 1:CAS:528:DC%2BD28Xmt1ehtbk%3D 16651744
19. H Lim KH Son HW Chang, et al. 2006 Inhibition of chronic skin inflammation by topical anti-inflammatory flavonoid preparation, Ato Formula Arch Pharm Res 29 503 507 10.1007/BF02969424 1:CAS:528:DC%2BD28XntFGmsrw%3D 16833019
20. I Longuet-Perret D Schmitt J Viac 1998 Tumour necrosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor Br J Dermatol 138 221 224 10.1046/j.1365-2133.1998.02064.x 1:CAS:528:DyaK1cXhtlyitLo%3D 9602864 (Pubitemid 28114121)
21. S Mahadevan Y Park 2008 Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses J Food Sci 73 R14 R19 1:CAS:528:DC%2BD1cXhtlWntL8%3D 18211362
22. M Mizuno Droy-Lefaix Mt L Packer 1996 Gingko biloba extract EGb 761 is a suppresser of AP-1 transcription factor stimulated by phorbol 12-myristate 13-acetate Biochem Mol Biol Int 39 395 401 1:CAS:528:DyaK2sXmtlWjsQ%3D%3D 8799468
23. G Neufeld T Cohen S Gengrinovitch, et al. 1999 Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 9 22 1:CAS:528: DyaK1MXlt1ygsQ%3D%3D 9872925
24. S Nishida H Satoh 2003 Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta Life Sci 72 2659 2667 10.1016/S0024-3205(03)00177-2 1:CAS:528:DC%2BD3sXisV2ks7o%3D 12672511 (Pubitemid 36369704)
25. D Parsad R Pandhi A Juneja 2003 Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo Clin Exp Dermatol 28 285 287 10.1046/j.1365-2230.2003.01207.x 1:STN:280:DC%2BD3s3ls1Cksw%3D%3D 12780716 (Pubitemid 36713819)
26. I Pernet V Sagot D Schmitt, et al. 1999 UVA1 and UVB radiation but not PGE2 stimulate IL-8 release in normal human keratinocytes Arch Dermatol Res 291 527 529 10.1007/s004030050448 1:CAS:528:DyaK1MXnsFSksrg%3D 10541884 (Pubitemid 29484134)
27. AT Pietrzak A Zalewska G Chodorowska, et al. 2008 Cytokines and anticytokines in psoriasis Clin Chim Acta 394 7 21 10.1016/j.cca.2008.04.005 1:CAS:528:DC%2BD1cXmvFems7k%3D 18445484
28. G Rimbach K Gohil S Matsugo, et al. 2001 Induction of glutathione synthesis in human keratinocytes by Ginkgo biloba extract (EGb761) Biofactors 15 39 52 10.1002/biof.5520150104 1:CAS:528:DC%2BD3MXovFOjsb8%3D 11673643
29. C Rosenberger C Solovan AD Rosenberger, et al. 2007 Upregulation of hypoxia-inducible factors in normal and psoriatic skin J Invest Dermatol 127 2445 2452 10.1038/sj.jid.5700874 1:CAS:528:DC%2BD2sXhtVeisb7J 17495954 (Pubitemid 47619751)
30. SM Sagar D Yance RK Wong 2006 Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1 Curr Oncol 13 14 26 1:STN:280:DC%2BD2szmt1Whtg%3D%3D 17576437
31. JR Smith VB Lanier RM Braziel, et al. 2007 Expression of vascular endothelial growth factor and its receptors in rosacea Br J Ophthalmol 91 226 229 10.1136/bjo.2006.101121 17244661 (Pubitemid 46202875)
32. H Takematsu H Tagami 1993 Mode of release of interleukin-8 from proliferating human epidermal keratinocytes in vitro Exp Dermatol 2 121 124 10.1111/j.1600-0625.1993.tb00019.x 1:CAS:528:DyaK2cXhs1Wmsrc%3D 8162328 (Pubitemid 23344563)
33. S Trompezinski A Denis D Schmitt, et al. 2003 Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNFalpha Arch Dermatol Res 295 112 116 10.1007/s00403-003-0402-y 1:CAS:528:DC%2BD3sXls1ygu70%3D 12811578 (Pubitemid 36960540)
34. S Trompezinski I Pernet D Schmitt, et al. 2001 UV radiation and prostaglandin E2 up-regulate vascular endothelial growth factor (VEGF) in cultured human fibroblasts Inflamm Res 50 422 427 10.1007/PL00000265 1:CAS:528:DC%2BD3MXnsFCrsrY%3D 11556523
35. J Viac S Palacio D Schmitt, et al. 1997 Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes Arch Dermatol Res 289 158 163 10.1007/s004030050172 1:CAS:528:DyaK2sXjtFSgtbg%3D 9128764 (Pubitemid 27107566)
36. Z Wei Q Peng Lau Bh, et al. 1999 Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells Gen Pharmacol 33 369 375 10.1016/S0306-3623(99)00027-0 1:CAS:528:DyaK1MXns1GhsbY%3D 10553877 (Pubitemid 29507455)
37. YP Xia B Li D Hylton, et al. 2003 Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis Blood 102 161 168 10.1182/blood-2002-12-3793 1:CAS:528:DC%2BD3sXltFemurw%3D 12649136 (Pubitemid 36759650)
38. PY Yang YC Rui L Zhang, et al. 2002 Expression of vascular endothelial growth factor in U937 foam cells and the inhibitory effect of drugs Yao Xue Xue Bao 37 86 89 1:CAS:528:DC%2BD38XitlCqsr4%3D 12579948
39. T Yoshikawa Y Naito M Kondo 1999 Ginkgo biloba leaf extract: review of biological actions and clinical applications Antioxid Redox Signal 1 469 480 10.1089/ars.1999.1.4-469 1:CAS:528:DC%2BD3cXjsleru7c%3D 11233145
40. L Zhang YC Rui PY Yang, et al. 2002 Inhibitory effects of Ginkgo biloba extract on vascular endothelial growth factor in rat aortic endothelial cells Acta Pharmacol Sin 23 919 923 1:CAS:528:DC%2BD38XnvFGlu7s%3D 12370096
41. SX Zheng LJ Zhou ZL Chen, et al. 2000 Bilobalide promotes expression of glial cell line-derived neurotrophic factor and vascular endothelial growth factor in rat astrocytes Acta Pharmacol Sin 21 151 155 1:CAS:528: DC%2BD3cXhtFChtro%3D 11263262